Profile
Andreas Pahl is Chief Executive Officer at Simris Biologics GmbH since 2026 and Managing Director at Heidelberg Pharma Research GmbH since 2012.
Former roles include Chief Executive Officer at Heidelberg Pharma AG from 2024 to 2025, Head-Late Pharmacology at Takeda Pharmaceutical Co., Ltd., Professor-Pharmacology & Toxicology at Friedrich-Alexander University of Erlangen-Nuremberg, Professor at Technical University of Berlin, Chief Scientific Officer at Heidelberg Pharma AG, Head-Late Pharmacology at Nycomed GmbH, and Member-Supervisory Board at Emergence Therapeutics AG.
Education includes undergraduate studies at Humboldt-Universität zu Berlin.
Andreas Pahl active positions
| Companies | Position | Start |
|---|---|---|
Heidelberg Pharma Research GmbH
Heidelberg Pharma Research GmbH Miscellaneous Commercial ServicesCommercial Services Engages in researching biotechnology | Chief Executive Officer | 2024-01-31 |
Simris Biologics GmbH
Simris Biologics GmbH Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company that identifies compounds in microalgae and cyanobacteria | Chief Executive Officer | 2026-07-14 |
Former positions of Andreas Pahl
| Companies | Position | End |
|---|---|---|
| HEIDELBERG PHARMA AG | Chief Executive Officer | 2025-11-23 |
Nycomed GmbH
Nycomed GmbH Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Corporate Officer/Principal | - |
| TAKEDA PHARMACEUTICAL COMPANY LIMITED | Corporate Officer/Principal | - |
Emergence Therapeutics AG
Emergence Therapeutics AG Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company which develops novel antibody drugs | Director/Board Member | - |
Friedrich-Alexander University of Erlangen-Nuremberg
Friedrich-Alexander University of Erlangen-Nuremberg Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Training of Andreas Pahl
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 10 |
|---|---|
Takeda Pharmaceutical Co., Ltd.
Takeda Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Engages in the research, development, manufacturing and marketing of pharmaceutical products | Health Technology |
Heidelberg Pharma AG
Heidelberg Pharma AG Pharmaceuticals: MajorHealth Technology Develops cancer therapies | Health Technology |
Friedrich-Alexander University of Erlangen-Nuremberg
Friedrich-Alexander University of Erlangen-Nuremberg Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Technical University of Berlin
Technical University of Berlin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Humboldt-Universität zu Berlin
Humboldt-Universität zu Berlin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Heidelberg Pharma AG /Old/
Heidelberg Pharma AG /Old/ Miscellaneous Commercial ServicesCommercial Services Provides drug development services | Commercial Services |
Nycomed GmbH
Nycomed GmbH Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Health Technology |
Heidelberg Pharma Research GmbH
Heidelberg Pharma Research GmbH Miscellaneous Commercial ServicesCommercial Services Engages in researching biotechnology | Commercial Services |
Emergence Therapeutics AG
Emergence Therapeutics AG Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company which develops novel antibody drugs | Health Technology |
Simris Biologics GmbH
Simris Biologics GmbH Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company that identifies compounds in microalgae and cyanobacteria | Commercial Services |
- Stock Market
- Insiders
- Andreas Pahl
















